Chemical genetic screen identifies lithocholic acid as an anti-aging
                        compound that extends yeast chronological life span in a TOR-independent
















































Aging of multicellular and unicellular eukaryotic 
organisms is a multifactorial biological phenomenon 
that has various causes and affects a plethora of cellular 
activities [1]. These numerous activities are modulated 

















































pathways that are conserved across phyla and include 
the insulin/insulin-like growth factor 1 (IGF-1), AMP-
activated protein  kinase/target of rapamycin  (AMPK/ 
TOR) and cAMP/protein kinase A (cAMP/PKA) 
pathways [2-5]. By sharing a compendium of protein 
kinases and adaptor proteins, the insulin/IGF-1, 







































kinase  A  (cAMP/PKA)  signaling  pathways  that  are  under  the  stringent  control  of  calorie  availability.  We  designed  a
chemical genetic screen for small molecules that increase the chronological life span of yeast under CR by targeting lipid
metabolism  and  modulating  housekeeping  longevity  pathways  that  regulate  longevity  irrespective  of  the  number  of





that  LCA  modulates  housekeeping  longevity  assurance  pathways  by  suppressing  lipid‐induced  necrosis,  attenuating
mitochondrial fragmentation, altering oxidation‐reduction processes in mitochondria, enhancing resistance to oxidative and
thermal stresses, suppressing mitochondria‐controlled apoptosis, and enhancing stability of nuclear and mitochondrial DNA. 
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network regulating longevity [2-4,6,7]. This network 
may also include several proteins that currently are not 
viewed as being in any of these three pathways 
[2,3,8,9]. Moreover, this network responds to the age-
related partial mitochondrial dysfunction and is 
modulated by mitochondrially produced reactive 
oxygen species (ROS) [3,8,10,11]. By sensing the 
nutritional status of the whole organism as well as the 
intracellular nutrient and energy status, functional state 
of mitochondria, and concentration of ROS produced in 
mitochondria, the longevity network regulates life span 
across species by coordinating information flow along 
its convergent, divergent and multiply branched 
signaling pathways. 
 
By defining the organismal and intracellular nutrient 
and energy status, nutrient intake plays an important 
role in modulating life span and influences age-related 
pathologies [12,13]. Two dietary regimens are known to 
have the most profound life-extending effects across 
species and to improve overall health by delaying the 
onset of age-related diseases. They include: 1) caloric 
restriction (CR), a diet in which only calorie intake is 
reduced but the supply of amino acids, vitamins and 
other nutrients is not compromised [13-15]; and 2) 
dietary restriction (DR), in which the intake of nutrients 
(but not necessarily of calories) is reduced by limiting 
food supply without causing malnutrition [16-18]. In a 
“TOR-centric” view of longevity regulation, TOR alone 
governs the life-extending and health-improving effects 
of CR/DR by: 1) integrating the flow of information on 
the organismal and intracellular nutrient and energy 
status from the protein kinases AMPK, PKA, 
PKB/AKT (the insulin/IGF-1 pathway) and ERK1/2 
(the PKA-inhibited Raf/MEK/ERK protein kinase 
cascade) as well as from the mitochondrial redox 
protein P66
Shc; 2) sensing the intracellular levels of 
amino acids in an AMPK-independent manner; and 3) 
operating as a control center which, based on the 
information it has gathered and processed, modulates 
many longevity-related processes in a sirtuin-
independent fashion [19-21]. The inability of CR to 
increase the replicative life span (RLS) of yeast mutants 
lacking components of the TOR pathway [22] and the 
lack of the beneficial effect of DR on life span in worms 
with reduced TOR signaling [23,24] support the 
proposed central role for TOR in orchestrating the life-
extending effect of CR/DR in these two longevity 
paradigms. Moreover, while the postulated by the TOR-
centric model dispensability of sirtuins for the longevity 
benefit associated with DR has been confirmed in 
worms [24], the importance of the sirtuin Sir2p in 
mediating the life-extending effect of CR in 
replicatively aging yeast is debated [22,25-27]. 
Noteworthy, while TOR is a central regulator of the 
life-extending effect of CR in replicatively aging yeast, 
the longevity benefit associated with CR in 
chronologically aging yeast is mediated by a signaling 
network that includes: 1) the TOR and cAMP/PKA 
pathways converged on Rim15p, which therefore acts as 
a nutritional integrator; and 2) some other, currently 
unknown pathways that are not centered on Rim15p [6]. 
Considering the likely convergence of the insulin/IGF-
1, AMPK/TOR and cAMP/PKA signaling pathways 
into a network regulating longevity in worms, fruit flies 
and mammals (see above), it is conceivable that - akin 
to TOR - the insulin/IGF-1 and cAMP/PKA pathways 
may contribute to the beneficial effect of CR/DR on 
their longevity. Although some findings in worms, fruit 
flies and mammals support the involvement of the 
insulin/IGF-1 pathway in the longevity benefit 
associated with CR/DR, other data imply that such 
benefit is independent of insulin/IGF-1 (reviewed by 
Narasimhan  et al. [3]). The role of cAMP/PKA 
signaling in the life-extending effect of CR/DR in these 
multicellular eukaryotes remains to be tested. 
Importantly, the recently reported in worms 
involvement of both independent and overlapping 
pathways in life span extension by different DR 
regimens [28] supports the notion that the longevity 
benefit associated with nutrient limitation is mediated 
by a signaling network that integrates several pathways.  
 
Akin to CR and DR regimens, certain pharmacological 
interventions can extend longevity across phyla and 
improve health by beneficially influencing age-related 
pathologies. Noteworthy, all of the currently known 
anti-aging compounds increase life span under non-CR 
or non-DR conditions (Table S1). Under such 
conditions, these compounds have been shown to: 1) 
provide the longevity and health benefits associated 
with CR and DR, but without restricting caloric and 
nutrient intake; and 2) mimic numerous life-extending 
effects of CR and DR on gene expression pattern, 
metabolic and physiological processes, and stress 
response pathways. Therefore, the names “CR 
mimetics” and “DR mimetics” have been coined for 
them [29,30]. Importantly, most CR mimetics and DR 
mimetics target signaling pathways that modulate 
longevity in response to the organismal and intracellular 
nutrient and energy status, including the insulin/IGF-1 
and AMPK/TOR pathways as well as the sirtuin-
governed protein deacetylation module of the longevity 
signaling network integrating these pathways (Table 
S1). Furthermore, such compounds as resveratrol, 
metformin and mianserin increase life span only under 
non-CR or non-DR conditions, but are unable to do so if 
the supply of calories or nutrients is limited [31-35]. 
Hence, one could envision that most, if not all, 
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they modulate longevity only in response to certain 
changes in the extracellular and intracellular nutrient 
and energy status of an organism. However, Li
+ in 
worms and rapamycin in fruits flies extend life span 
even under DR conditions [36,37]. It is likely therefore 
that some longevity pathways could be “constitutive” or 
“housekeeping” by nature, i.e., that they: 1) modulate 
longevity irrespective of the organismal and intra-
cellular nutrient and energy status; and 2) do not 
overlap (or only partially overlap) with the adaptable 
longevity pathways that are under the stringent control 
of calorie and/or nutrient availability. The challenge is 
to identify such housekeeping longevity pathways, 
perhaps by using a chemical screen for compounds that 
can extend longevity even under CR/DR conditions. 
Because under such conditions the adaptable pro-aging 
pathways are fully suppressed and the adaptable anti-
aging pathways are fully activated, a compound that can 
increase life span is expected to target the housekeeping 
longevity pathways.  
 
Noteworthy, two anti-aging compounds alter lipid 
levels in mammals and fruit flies under non-DR 
conditions. In fact, resveratrol treatment reduces the 
levels of the neutral lipids triacylglycerols (TAG) and 
increases free fatty acid (FFA) levels in mouse 
adipocytes [38]. Furthermore, feeding rapamycin to 
fruit flies results in elevated TAG levels [37]. Although 
it remains to be seen if such effects of resveratrol and 
rapamycin on lipid levels play a casual role in their anti-
aging action under non-DR conditions, it should be 
stressed that lipid metabolism has been shown to be 
involved in longevity regulation in yeast [39,40], worms 
[9,41-43], fruit flies [41,44] and mice [38,41,45-48]. 
We recently proposed a mechanism linking yeast 
longevity and lipid dynamics in the endoplasmic 
reticulum (ER), lipid bodies and peroxisomes. In this 
mechanism, a CR diet extends yeast chronological life 
span (CLS) by activating FFA oxidation in peroxisomes 
[39,40]. It is conceivable that the identification of small 
molecules targeting this mechanism could yield novel 
anti-aging compounds. Such compounds can be used as 
research tools for defining the roles for different 
longevity pathways in modulating lipid metabolism and 
in integrating lipid dynamics with other longevity-
related processes. Furthermore, the availability of such 
compounds would enable a quest for housekeeping 
longevity assurance pathways that do not overlap (or 
only partially overlap) with the adaptable TOR and 
cAMP/PKA pathways. Moreover, such compounds 
would have a potential to be used as pharmaceutical 
agents for increasing life span and promoting healthy 
aging by delaying the onset of age-related diseases, 
regardless of an organism’s dietary regimen. 
We sought to identify small molecules that increase the 
CLS of yeast under CR conditions by targeting lipid 
metabolism and modulating housekeeping longevity 
assurance pathways. Our chemical genetic screen 
identified lithocholic acid (LCA) as one of such small 
molecules. We provide evidence that LCA extends 
longevity of chronologically aging yeast through two 
different mechanisms. In one mechanism, this bile acid 
targets - regardless of the number of available calories - 
housekeeping longevity assurance pathways that do not 
overlap with the adaptable TOR and cAMP/PKA 
pathways and modulate a compendium of pro- and anti-
aging processes. In the other mechanism, LCA targets 
the adaptable cAMP/PKA pathway under non-CR 
conditions by unmasking the previously unknown anti-




Our rationale for choosing a mutant strain and 
growth conditions to screen compound libraries for 
anti-aging small molecules 
 
To perform a chemical genetic screen for small 
molecules that increase the CLS of yeast by targeting 
lipid metabolism, we chose the single-gene-deletion 
mutant strain pex5Δ. Because pex5Δ lacks a cytosolic 
shuttling receptor for peroxisomal import of Fox1p and 
Fox2p, these two enzymes of the β-oxidation of FFA 
reside in the cytosol of pex5Δ cells [49] (Figure 1A). In 
contrast, the Pex5p-independent peroxisomal import of 
Fox3p, the third enzyme of the FFA β-oxidation 
pathway, sorts it to the peroxisome in pex5Δ cells [49]. 
By spatially separating Fox1p and Fox2p from Fox3p 
within a cell, the pex5Δ mutation impairs FFA oxidation 
(Figure 1A). In chronologically aging yeast grown 
under CR conditions on 0.2% or 0.5% glucose, 
peroxisomal FFA oxidation regulates longevity by 1) 
efficiently generating acetyl-CoA to synthesize the bulk 
of ATP in mitochondria; and 2) acting as a rheostat that 
modulates the age-related dynamics of FFA and 
diacylglycerol (DAG), two regulatory lipids known to 
promote longevity-defining cell death [39,40,50]. 
Unlike CR yeast, chronologically aging non-CR yeast 
grown on 1% or 2% glucose are unable to generate 
significant quantities of ATP by oxidizing peroxisome-
derived acetyl-CoA in mitochondria and, instead, 
produce the bulk of ATP via glycolytic oxidation of 
glycogen- and trehalose-derived glucose [39,40]. 
Consistent with the essential role of peroxisomal FFA 
oxidation as a longevity assurance process only under 
CR, the pex5Δ mutation substantially shortened the CLS 
of CR yeast but caused a significantly lower reduction 
of longevity in non-CR yeast, especially in yeast grown 
on 2% glucose (Figures 1B to F). 
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oxidation modulates, perhaps via several negative 
feedback loops, the following three processes: 1) the 
ER-confined biosynthesis of TAG from FFA and DAG; 
2) the subsequent deposition of TAG, the major neutral 
lipid reserves, in lipid bodies; and 3) the consequent 
lipolysis of deposited TAG and the resulting formation 
of FFA and DAG [39,40]. By impairing the ability of 
peroxisomal FFA oxidation to act as a rheostat that 
regulates cellular aging by modulating the age-related 
dynamics of FFA, DAG and TAG in the ER and lipid 
bodies, the pex5Δ mutation caused the accumulation of 
the closely apposed ER membranes and ER-originated 
lipid bodies in CR yeast (Figure 1J). Of note, these 
morphological features of pex5Δ yeast under CR were 
similar to those observed in a mouse model for the 
peroxisome biogenesis disorder Zellweger syndrome 
with hepatocyte-specific elimination of the PEX5 gene 
[51]. Furthermore, the pex5Δ mutation increased the 
concentrations of FFA, DAG and TAG in CR yeast 
(Figures 1G to I), promoting their buildup in the ER and 
lipid bodies (Figure 1K). CR yeast carrying the pex5Δ 
mutation also accumulated the ER-derived and lipid 
bodies-deposited ergosteryl esters (EE) neutral lipid 
species (Figure 1K). 
 
Following a short-term exposure to exogenous FFA 
(palmitoleic acid or oleic acid) or DAG, wild-type (WT) 
cells grown under CR conditions died (Figure S1A). 
The vast majority of these WT cells displayed 
propidium iodide (PI) positive staining characteristic of 
the loss of plasma membrane integrity, a hallmark event 
of necrotic cell death (Figures S1B and S1C). In 
contrast, only a minor portion of these WT cells 
displayed Annexin V positive staining used to visualize 
the externalization of phosphatidylserine, a hallmark 
event of apoptotic cell death (Figures S1B and S1C). 
Thus, a brief exposure of WT cells grown under CR 
conditions to exogenous FFA or DAG caused their 
necrotic, not apoptotic, death. Importantly, we found 
that the pex5Δ mutation enhances the susceptibility of 
CR yeast to necrotic death caused by a short-term 
exposure to exogenous FFA or DAG (Figures S1A and 
S1C), perhaps due to the increased concentrations of 
endogenous FFA and DAG seen in pex5Δ cells under 
CR (Figures 1G and H). 
 
In addition to its effect on lipid metabolism and lipid-
induced necrotic cell death, the pex5Δ mutation also 
altered mitochondrial morphology and oxidation-
reduction processes in mitochondria of CR yeast. In 
fact, this mutation caused the fragmentation of a tubular 
mitochondrial network into individual mitochondria 
under CR conditions (Figures S2A and S2B). 
Furthermore, in CR yeast the pex5Δ mutation 1) greatly 
reduced the rate of oxygen consumption by mitochondria 
(Figure S2C); 2) substantially decreased the mito-
chondrial membrane potential (Figure S2D); and 3) 
diminished the level of intracellular ROS (Figure S2E), 
known to be generated mostly as by-products of 
mitochondrial respiration [10,52]. Interestingly, all these 
mitochondrial abnormalities in pex5Δ yeast under CR 
were reminiscent of changes in mitochondrial morpholo-
gy and functions seen in mice with hepatocyte-specific 
elimination of the PEX5 gene, a model for the peroxi-
some biogenesis disorder Zellweger syndrome [51]. 
 
Besides its profound effect on lipid metabolism, lipid-
induced necrosis, mitochondrial morphology and 
functions, the pex5Δ mutation also 1) reduced the 
resistance of chronologically aging CR yeast to chronic 
oxidative, thermal and osmotic stresses (Figure S3A); 2) 
sensitized CR yeast to death that was initiated in 
response to a short-term exposure to exogenous 
hydrogen peroxide or acetic acid (Figure S3B) and that 
is known to be caused by mitochondria-controlled 
apoptosis [53,54]; and 3) elevated the frequencies of 
deletion and point mutations in mitochondrial and 
nuclear DNA of CR yeast (Figures S3C to S3E). 
 
The profound changes in cell morphology and 
physiology, stress resistance, susceptibility to lipid-
induced necrosis and mitochondria-controlled 
apoptosis, and stability of nuclear and mitochondrial 
DNA seen in pex5Δ yeast under CR conditions 
coincided with considerable changes in their proteome. 
Indeed, our mass spectrometry-based quantitative 
proteomic analysis of proteins recovered in total cell 
lysates as well as in purified ER and mitochondria 
revealed that the pex5Δ mutation altered the abundance 
of many proteins (Figure 2A). Protein species that were 
depleted or enriched in the total cell lysate, ER and 
mitochondria of pex5Δ yeast grown under CR 
conditions included proteins involved in a number of 
cellular processes (Figure 2B). Importantly, lack of 91 
of these proteins increased the CLS of yeast under CR 
(Figure 2B), suggesting their essential pro-aging role in 
longevity regulation when calorie supply is limited. 
Noteworthy, 58 of the genes encoding these proteins 
and termed gerontogenes (i.e., the genes whose mutant 
alleles extend life span; [55]) have not been previously 
known as being critical for defining the CLS of yeast. 
The identities of protein species that were depleted or 
enriched in pex5Δ yeast grown under CR conditions, the 
extent to which their levels were altered and the names 
of gerontogenes identified in our functional analysis 
will be reported elsewhere (Goldberg et al., manuscript 
in preparation). Importantly, for most of these proteins  
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fold increase or decrease in the level of a protein 




















































correlation with the fold increase or decrease 
(respectively) in the mean CLS of a mutant strain 






















































ER  and  mitochondria  of  CR  yeast.  (A)  The  spectra  of  proteins  recovered  in  total  cell  lysates,  purified  ER  and
mitochondria of WT and pex5Δ cells that were grown under CR on 0.2% glucose and taken for analyses at the indicated

















































Altogether, these findings imply that, by impairing 
peroxisomal FFA oxidation and affecting lipid 
metabolism in the ER and lipid bodies, the pex5Δ 
mutation alters the levels of numerous pro- and anti-
aging proteins and impacts many longevity-related 
processes, thereby shortening the CLS of yeast when 
calorie supply is limited. We therefore chose the short-
lived pex5Δ strain to carry out a chemical genetic screen 
for anti-aging compounds that target lipid metabolism 














































A chemical genetic screen for small molecules that 
extend the CLS of yeast under CR conditions 
 
To facilitate a high-throughput screen of compound 
libraries for anti-aging small molecules, we adopted a 
previously described microplate assay [56] for 
measuring CLS by monitoring optical density at 600 nm 
(OD600) (Figure 3A). In our assay, a small aliquot of the 
pex5Δ culture grown in a nutrient-rich medium 
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96-well master microplate containing the same growth 
medium and a compound from a commercially 
available library. At days 1, 7, 10 and 14 of the 
incubation of master microplates, a small aliquot of 
each culture was transferred into individual wells of a 
new (replica) microplate containing growth medium 
only. Following incubation of replica microplates for 16 
hours, the OD600 of the culture in each well of the 
replica microplate was measured. Importantly, we found 
that under such conditions the OD600 of a cell culture in 
a well of the replica microplate correlates with the 
number of viable cells in the corresponding well of the 
master microplate (Figure 3B). To calculate survival at 
each time point, the OD600 at a particular time point was 
divided by the OD600 at day 1. By translating our 
microplate assay into high-throughput format and 
screening representative compounds from the NIH 
Clinical Collection, Prestwick Chemical Inc. and 
Sigma-LOPAC commercial libraries, we identified 
“lead” compounds. The subsequent “cherry-picking” 
analysis of these small molecules revealed “hit” 
compounds that in our microplate assay reproducibly 
extended the CLS of pex5Δ. Using the web-based 
eMolecules searching engine, we identified 
commercially available structural analogs of the hit 
compounds and then tested their life-extending efficacy 
in our microplate assay for measuring the CLS of 
pex5Δ. By screening the total of approximately 19,000 
representative compounds from seven commercial 
libraries, we identified 24 small molecules that greatly 
extend the CLS of pex5Δ under CR and belong to 5 
chemical groups (Figure 3C). Group I consisted of 6 
bile acids, including lithocholic acid (LCA), 
deoxycholic acid (DCA), chenodeoxycholic acid 
(CDCA), cholic acid (CA), dehydrocholic acid (DHCA) 
and hyodeoxycholic acid (HDCA) (Figures 3C and S5). 
Noteworthy, the anti-aging efficacy of these bile acids 
correlated with their hydrophobicity. In fact, LCA - the 
most hydrophobic bile acid species [57] - displayed the 
highest ability to delay chronological aging of pex5Δ 
under CR conditions in the microplate assay (Figure 
S5). The identities of small molecules that belong to 
groups II to V (Figure 3C) of the anti-aging compounds 
identified in our screen and the structure-activity 
analysis of their life-extending potential will be reported 
elsewhere (Goldberg et al., manuscript in preparation). 
 
Noteworthy, none of the small molecules that has been 
shown to extend CLS (i.e., caffeine, methionine 
sulfoximine, rapamycin and spermidine; Table S1; 
[56,58,59]) and/or RLS (i.e., rapamycin and resveratrol; 
Table S1; [27,31]) in yeast has been identified in our 
screen for compounds capable of increasing the CLS of 
pex5Δ under CR. Furthermore, none of these currently 
known life-extending molecules is structurally related to 
the anti-aging compounds that we revealed. Thus, it is 
likely that LCA and all other novel anti-aging 
compounds identified in our screen target longevity-
related cellular processes that are not modulated by the 
presently known anti-aging small molecules. Because 
our screen was aimed at identifying compounds that 
extend yeast longevity by targeting lipid metabolism, it 
is conceivable that the age-related dynamics of TAG, 
FFA and DAG is one of such cellular processes.  
 
Pharmacophore modeling of the anti-aging potential 
of bile acids  
 
Similar to their effect on pex5Δ, some of the group I 
anti-aging compounds extended the CLS of WT strain 
under CR conditions. Specifically, LCA and two other 
bile acids - DCA and CDCA - increased both the mean 
and maximum CLS of WT yeast grown under CR on 
0.2% glucose (Figures 4A to 4D). Moreover, DHCA 
increased only the mean CLS of WT yeast under CR at 
0.2% glucose, whereas HDCA increased only their 
maximum CLS (Figures 4A to 4D). Akin to its highest 
life-extending efficacy in pex5Δ under CR, the most 
hydrophobic bile acid - LCA [57] - provided WT cells 
with the greatest longevity benefit when calorie supply 
was limited. In fact, LCA increased the mean CLS of 
WT strain under CR at 0.2% glucose by almost 250% 
and its maximum CLS by more than 200% (Figures 4A 
to D). Our comparative analysis of the structural 
differences between various bile acids and their relative 
life-extending efficacies revealed that the positions 6, 7 
and 12 in the six-member rings B and C of the steroid 
nucleus are important for the anti-aging potential of a 
bile acid. Indeed, the ability of LCA to extend both the 
mean and maximum CLS of WT yeast under CR can 
be: 1) eliminated (with respect to the mean CLS) or 
greatly reduced (with respect to the maximum CLS) by 
attaching an α-oriented hydroxyl group at the position 6 
(as in HDCA); 2) greatly reduced (with respect to both 
the mean and maximum CLS) by attaching an α-
oriented hydroxyl group at the position 7 (as in CDCA); 
and 3) greatly reduced (with respect to both the mean 
and maximum CLS) by attaching an α-oriented 
hydroxyl group at the position 12 (as in DCA) (Figures 
4B to E). All these modifications to the structure of 
LCA increase polarity of the hydrophilic (concave) side 
[α-face] of the steroid nucleus by positioning a hydroxyl 
group below the nucleus and axially to its plane (Figure 
4E). Furthermore, the anti-aging potential of LCA can be 
abolished by attaching a β-oriented hydroxyl group at the 
position 7 (as in UDCA), thereby conferring polarity to 
the hydrophobic (convex) side [β-face] of the steroid 
nucleus by positioning a hydroxyl group above the 
nucleus and equatorially to its plane (Figures 4B to E).  
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oriented hydroxyl groups (as in CA) or two keto groups 
(as in DHCA) at the positions 7 and 12 eliminated the 
ability of LCA to extend both the mean and maximum 
CLS of WT yeast under CR (Figures 4B to E). 
Altogether, the results of our pharmacophore modeling 
of the anti-aging potential of bile acids imply that the 
maintenance of the minimal polarity of both the 
hydrophilic (concave) and hydrophobic (convex) sides 
of the steroid nucleus - by avoiding the presence of 
polar substituents at the positions 6, 7 and 12 - is 
mandatory for the extreme life-extending efficacy of 
LCA under CR conditions. Such stringent structural 
requirements are consistent with a target specificity of 
LCA action as an anti-aging small molecule.  
 
LCA extends the CLS of WT yeast under both CR 
and non-CR conditions, although to a different extent  
 
If added to growth medium at the time of cell 
inoculation, LCA increased both the mean and 
maximum CLS of WT strain not only under CR at 0.2% 
or 0.5% glucose (Figures 5A, 5B and 5G - 5I) but also 
under non-CR conditions administered by culturing 
yeast in medium initially containing 1% or 2% glucose 
(Figures 5C, 5D and 5G - 5I). At any tested 
concentration of glucose in growth medium, LCA 
displayed the greatest beneficial effect on both the mean 
and maximum CLS of WT strain if used at a final 
concentration of 50 μM (Figures 5E and 5F). It should 
be stressed that the life-extending efficacy of 50 μM 
LCA under CR exceeded that under non-CR conditions, 
being inversely proportional to the concentration of 
glucose in growth medium and thus in correlation with 
the extent of calorie supply limitation (Figures 5G to 
5I). Importantly, although 50 μM LCA displayed a 
profound effect on CLS, it did not cause significant 
changes in growth of WT strain at any tested 
concentration of glucose in medium. In fact, both 
growth rate in logarithmic phase and time prior to entry 
into stationary (ST) phase were similar for WT cells 
cultured in medium with or without LCA (Figure S6). 
 
LCA extends the CLS of WT yeast under CR by 
modulating a compendium of longevity-related 
processes  
 
Our chemical genetic screen identified LCA as a 
compound that under CR conditions extends the CLS of 
pex5Δ, a prematurely aging mutant strain displaying 
profound changes in lipid metabolism, lipid-induced 
necrotic cell death, mitochondrial morphology and 
functions, stress resistance, mitochondria-controlled 
apoptosis, and stability of nuclear and mitochondrial 
DNA. We found that LCA also greatly increases the 
mean and maximum CLS of WT yeast limited in calorie 
supply. This finding prompted us to investigate how the 
exposure of WT cells to LCA under CR conditions 
influences a compendium of longevity-related processes 
impaired in pex5Δ.     
    
Consistent with its sought-after effect on lipid 
metabolism in the ER, lipid bodies and peroxisomes, 
LCA elevated the concentration of TAG in WT cells 
that entered the non-proliferative ST phase under CR at 
0.2% glucose (Figure 6A). Furthermore, under these 
conditions LCA also substantially reduced the 
intracellular levels of FFA and DAG in WT yeast that 
reached reproductive maturation by entering into ST 
phase (Figures 6B and 6C). Moreover, LCA greatly 
reduced the susceptibility of reproductively mature WT 
cells under CR to necrotic cell death that was caused by 
a short-term exposure to exogenous FFA or DAG and 
defined by Annexin V
-/PI
+ staining (Figures 6D to 6I).  
     The exposure of reproductively mature WT cells to 
LCA under CR conditions also influenced other 
longevity-related processes impaired in pex5Δ, 
including those confined to mitochondria. Indeed, in 
WT cells that entered the non-proliferative ST phase 
under CR at 0.2% glucose, LCA 1) attenuated the 
fragmentation of a tubular mitochondrial network into 
individual mitochondria (Figure 7A); 2) elevated the 
rate of oxygen consumption by mitochondria (Figure 
7B); 3) reduced the mitochondrial membrane potential 
(Figure 7C); and 4) decreased the level of intracellular 
ROS (Figure 7D) known to be generated mainly in 
mitochondria [10,52]. 
 
Moreover, in WT yeast that under CR conditions 
reached reproductive maturation by entering into ST 
phase, LCA 1) enhanced cell resistance to oxidative and 
thermal (but not to osmotic) stresses (Figure 7E); 2) 
reduced cell susceptibility to death triggered by a short-
term exposure to exogenous hydrogen peroxide or 
acetic acid (Figure 7F) known to be caused by 
mitochondria-controlled apoptosis [53,54]; and 3) 
decreased the frequencies of deletions and point 
mutations in mitochondrial and nuclear DNA (Figures 
7G to I). 
           
LCA extends yeast CLS independent of TOR, by 
modulating housekeeping longevity assurance 
pathways 
 
Our chemical genetic screen was aimed at identifying 
small molecules that can increase the CLS of yeast 
under CR by modulating housekeeping longevity 
pathways. Such pathways may regulate yeast longevity 
irrespective of the number of available calories and may 
not necessarily overlap (or may only partially overlap) 
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stringent control of calorie availability. In 




















































signaling pathways are the two adaptable longevity 
pathways that govern the life-extending effect of CR 







































































































Reduction of the Tor1p protein kinase activity in yeast 
placed on a CR diet or exposed to rapamycin prevents 
inhibitory phosphorylation of Atg13p, a key positive 
regulator of autophagy, thereby activating this essential 
anti-aging process (Figure 10A) [63,64]. Under CR 
conditions or in response to rapamycin, Tor1p is also 
unable to phosphorylate and activate the nutrient-
sensory protein kinase Sch9p [60,65]. The resulting 
inhibition of the Sch9p kinase activity suppresses its 
ability to attenuate protein synthesis in mitochondria, 













































Furthermore, by inhibiting the Sch9p kinase activity, 
CR restrains Sch9p from activating protein synthesis in 
the cytosol, thereby slowing down this essential pro-
aging process [60,62,65]. Moreover, the attenuation of 
the Sch9p kinase activity in CR yeast prevents the 
retention of Rim15p in the cytosol, hence allowing this 
nutrient-sensory protein kinase to enter the nucleus 
where it orchestrates an anti-aging transcriptional 
program by activating the stress response transcriptional 
activators Msn2p, Msn4p and Gis1p [58,62]. The 
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through the cAMP/PKA pathway, which is driven by 
glucose deprivation [5,6,62]. By preventing inhibitory 
phosphorylation of Atg13p, the reduction of the PKA 
kinase activity in CR yeast results in activation of 
autophagy (Figure 10A) [63,66]. In addition, by 
inhibiting the PKA kinase activity, CR suppresses the 
ability of PKA to activate protein synthesis in the 
cytosol [62]. Moreover, reduced PKA kinase activity in 













































thus turning on an anti-aging transcriptional program 
driven - in a Rim15p-dependent fashion - by these two 
transcriptional activators [27,62,67]. Noteworthy, the 
kinase activity of the cytosolic pool of Rim15p is 
inactivated through PKA-dependent phosphorylation 
(Figure 10A) [62]. Although some of the Rim15p 
phosphorylation targets are involved in longevity 
regulation and reside outside the nucleus [68], a role of 
such phosphorylation in the life-extending effect of CR 





















































































































































































color),  anti‐aging  processes  (displayed  in  red  color)  or  processes  whose  role  in  longevity  regulation  is  presently  unknown
(displayed in black color). Doted lines denote hypothetical processes. Abbreviations: PM, plasma membrane.   
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WT strain on a high- or low-calorie diet revealed that 
this compound increased CLS irrespective of the 
number of available calories (Figures 8A and 8B). 
Intriguingly, the extent to which LCA extended 
longevity was highest under CR conditions (Figures 8C 
and 8D), when the pro-aging processes modulated by 
the adaptable TOR and cAMP/PKA pathways are 
suppressed and the anti-aging processes are activated 
(Figure 8F). The life-extending efficacy of LCA in CR 
yeast significantly exceeded that in yeast on a high-
calorie diet (Figures 8C and 8D), in which the adaptable 
TOR and cAMP/PKA pathways greatly activate the 
pro-aging processes and suppress the anti-aging 
processes (Figure 8E). Altogether, these findings 
suggest that, consistent with its sought-after effect on a 
longevity signaling network, LCA mostly targets certain 
housekeeping longevity assurance pathways that do not 
overlap (or only partially overlap) with the adaptable 
TOR and cAMP/PKA pathways modulated by calorie 
availability (Figures 8E and 8F).  
 
Consistent with our assumption that LCA extends 
longevity not by modulating the adaptable TOR 
pathway (Figures 9E and 9F), lack of Tor1p did not 
impair the life-extending efficacy of LCA under CR 
(Figures 9A to 9D). Importantly, by eliminating a 
master regulator of this key adaptable pathway that 
shortens the CLS of yeast on a high-calorie diet, the 
tor1Δ mutation abolished the dependence of the anti-
aging efficacy of LCA on the number of available 
calories. In fact, LCA extended longevity of the tor1Δ 
mutant strain to a very similar degree under CR and 
non-CR conditions (Figures 9C and 9D). 
We next assessed how the adaptable cAMP/PKA 
pathway influences the life-extending efficacy of LCA 
in yeast on a high- or low-calorie diet. Although the 
ras2Δ mutation greatly decreases the PKA protein 
kinase activity by eliminating a GTP-binding protein 
that activates adenylate cyclase responsible for the 
synthesis of the PKA activator cAMP (Figures S7E and 
S7F) [62], it did not abolish the ability of LCA to 
extend CLS under CR and non-CR conditions (Figures 
S7A and S7B). However, the life-extending efficacy of 
LCA was decreased by the ras2Δ mutation, as 
compared to that seen in WT cells exposed to this 
compound (Figures S7C and S7D). In spite of such 
partial reduction of the anti-aging potential of LCA in 
ras2Δ, LCA still significantly increased its CLS under 
CR and non-CR conditions (Figures S7C and S7D). 
 
Thus, it seems that LCA extends longevity of 
chronologically aging yeast through two different 
mechanisms. Firstly, irrespective of the number of 
available calories, this bile acid targets certain house-
keeping longevity assurance pathways that 1) inhibit 
some pro-aging processes and/or activate some anti-
aging processes; and 2) do not overlap with the 
adaptable cAMP/PKA pathway modulated by calorie 
availability (Figure 10B). Secondly, we propose that 
LCA unmasks the anti-aging potential of PKA by 
activating PKA-dependent phosphorylation of the 
cytosolic pool of Rim15p (Figure 10B). Because such 
phosphorylation of Rim15p is known to inactivate its 
protein kinase activity (Figure 10A) [62], we 
hypothesize that, while the nuclear pool of Rim15p has 
a well established anti-aging function [5,6,27,62], the 
cytosolic pool of this nutrient-sensory protein kinase 
plays an essential pro-aging role by phosphorylating a 
compendium of proteins that promote aging only if 
phosphorylated (Figure 10B). Noteworthy, some of the 
Rim15p phosphorylation targets are involved in 
longevity regulation and reside outside the nucleus [68]. 
In our hypothesis, LCA can unmask the anti-aging 
potential of PKA only when PKA is activated by cAMP, 
i.e., under non-CR conditions (Figures 8E and F). 
Consistent with our hypothesis on the two mechanisms 
underlying the anti-aging effect of LCA, lack of Ras2p 
only partially and to the same extent reduced the life-
extending potential of LCA under both CR and non-CR 
conditions (Figures S7C and S7D), likely by impairing 
the mechanism in which LCA unmasks the anti-aging 
potential of PKA. The resulting inability of PKA to 
inhibit the proposed pro-aging role of the cytosolic pool 
of Rim15p in ras2Δ cells would make the Rim15p-
dependent pro-aging mechanism constitutively active in 
these cells, regardless of the number of available calories 
or presence of LCA (Figures S7E and S7F). 
 
The TOR and cAMP/PKA pathways converge on 
Rim15p whose nuclear pool plays a pivotal role in 
governing the life-extending effect of CR by enabling the 
establishment of an anti-aging transcriptional program 
driven by Msn2p, Msn4p and Gis1p (Figure 10A) 
[5,6,27,62]. Our evaluation of the life-extending efficacy 
of LCA in yeast lacking Rim15p further supported the 
notion that one of the two mechanisms underlying the 
anti-aging effect of this bile acid involves its ability to 
modulate certain housekeeping longevity assurance 
pathways that are not centered on Rim15p and do not 
overlap with the adaptable TOR and cAMP/PKA 
pathways. In fact, although the life-extending potential of 
LCA in rim15Δ was partially reduced (Figures S8C and 
S8D) due to the impairment of the Rim15p-centered 
mechanism of its anti-aging action (Figures S8E and 
S8F), LCA still significantly increased the CLS of 
rim15Δ under CR and non-CR conditions (Figures S8A 
to S8D). Importantly, by eliminating a key nutrient-
sensory protein kinase on which the adaptable TOR and 
cAMP/PKA pathways converge to regulate longevity in a 
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efficacy of LCA on the number of available calories 
































































































In this study, we designed a chemical genetic screen for 
small molecules that increase the CLS of yeast under 
CR conditions by targeting lipid metabolism and 
modulating housekeeping longevity pathways that 
regulate longevity irrespective of the number of 
available calories. Our screen identifies LCA as one of 
such molecules. Our analysis of how LCA influences 
various longevity-related processes and how it affects 
the CLS of yeast mutants impaired in the adaptable 
TOR and cAMP/PKA longevity pathways provided 
important new insights into mechanisms of longevity 









































LCA extends yeast CLS by modulating 
housekeeping longevity assurance processes that are 
not regulated by the adaptable TOR and cAMP/PKA 
signaling pathways  
 
Our findings imply that LCA extends longevity of 
chronologically aging yeast by targeting two different 
mechanisms. One mechanism extends longevity 
regardless of the number of available calories. This 
mechanism involves the LCA-governed modulation of 
certain housekeeping longevity assurance pathways that 
do not overlap with the adaptable TOR and cAMP/PKA 
pathways (Figure 10B). We identify a compendium of 
processes that compose LCA-targeted housekeeping 
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suppressing the pro-aging process [39,40,50] of lipid-
induced necrotic cell death, perhaps due to its observed 
ability to reduce the intracellular levels of FFA and 
DAG that trigger such death; 2) attenuating the pro-
aging process [69,70] of mitochondrial fragmentation, a 
hallmark event of age-related cell death; 3) altering 
oxidation-reduction processes in mitochondria - such as 
oxygen consumption, the maintenance of membrane 
potential and ROS production - known to be essential 
for longevity regulation [8,10,11,71]; 4) enhancing cell 
resistance to oxidative and thermal stresses, thereby 
activating the anti-aging process [11,39,40,72,73] of 
stress response; 5) suppressing the pro-aging process 
[69,70] of mitochondria-controlled apoptosis; and 6) 
enhancing stability of nuclear and mitochondrial DNA, 
thus activating the anti-aging process [74,75] of genome 
maintenance. The observed pleiotropic effect of LCA 
on a compendium of housekeeping longevity assurance 
processes implies that this bile acid is a multi-target 
life-extending compound that increases CLS in yeast by 
modulating a network of the highly integrated processes 
that are not controlled by the adaptable TOR and 
cAMP/PKA pathways. The major challenge now is to 
define the molecular mechanisms by which LCA 
modulates each of these pro- and anti-aging 
housekeeping processes and integrates them in 
chronologically aging yeast. 
 
The other mechanism underlying the life-extending 
effect of LCA in chronologically aging yeast increases 
life span only under non-CR conditions. This 
mechanism consists in LCA-driven unmasking of the 
previously unknown anti-aging potential of PKA, a key 
player in the adaptable cAMP/PKA pathway. We 
propose that LCA unveils the anti-aging potential of 
PKA by activating PKA-dependent phosphorylation of 
the cytosolic pool of Rim15p, a key nutrient-sensory 
protein kinase on which the adaptable TOR and 
cAMP/PKA pathways converge to regulate longevity in 
a calorie availability-dependent fashion (Figure 10B). 
Of note, the nuclear pool of Rim15p is well known for 
its anti-aging role in governing the life-extending effect 
of CR by enabling a pro-longevity transcriptional 
program driven by Msn2p, Msn4p and Gis1p (Figure 
10B) [6,62]. In our hypothesis 1) unlike its nuclear pool, 
the cytosolic pool of Rim15p has an essential pro-aging 
function in phosphorylating a compendium of its 
cytosolic target proteins [68] some of which promote 
aging only if phosphorylated (Figure 10B); 2) under 
non-CR conditions LCA activates the PKA-dependent 
phosphorylation of Rim15p (Figure 10B); and 3) 
because the phosphorylation of Rim15p inactivates its 
protein kinase activity [62], the dephosphorylation of 
pro-aging target proteins of Rim15p in the cytosol by 
phosphatases inhibits the ability of these target proteins 
to promote aging (Figure 10B). To test the validity of 
our hypothesis, we are currently evaluating how genetic 
manipulations that alter the abundance of various extra-
nuclear target proteins of Rim15p or affect their 
phosphorylation status influence the life-extending 
efficacy of LCA. 
      
Bile acids are beneficial to health and longevity 
across phyla 
 
It should be stressed that, although we found that LCA 
greatly extends yeast longevity, yeast do not synthesize 
this or any other bile acid found in mammals [57,76]; 
our mass spectrometry-based analysis of the total yeast 
lipidome has confirmed lack of endogenous bile acids. 
One could envision that during evolution yeast have lost 
the ability to synthesize bile acids but have maintained 
the life-extending response to these biologically active 
molecules by retaining certain longevity-related 
processes that are sensitive to regulation by bile acids. 
Alternatively, one could think that during evolution 
yeast have developed the ability to sense bile acids 
produced by mammals (and/or bile acid-like lipids 
synthesized by worms), recognize these mildly toxic 
molecules as environmental stressors providing 
hormetic benefits and/or as indicators of the state of the 
environment or food supply, and then to respond by 
undergoing certain life-extending changes to their 
physiology that ultimately increase their chances of 
survival. It is conceivable therefore that the life-
extending potential of LCA and other bile acids as well 
as, probably, the mechanisms underlying their anti-
aging action are evolutionarily conserved.  
 
 In fact, following their synthesis from cholesterol in the 
intestine, hypodermis, spermatheca and sensory neurons 
of worms, bile acid-like dafachronic acids (including 3-
keto-LCA) are delivered to other tissues where they 
activate the DAF-12/DAF-16 signaling cascade that in 
turn orchestrates an anti-aging transcriptional program, 
thereby increasing the life span of the entire organism 
[41]. Bile acids also provide health benefits to 
mammals. Synthesized from cholesterol in hepatocytes 
of the liver, these amphipathic molecules have been for 
a long time considered to function only as trophic 
factors for the enteric epithelium and as detergents for 
the emulsification and absorption of dietary lipids and 
fat-soluble vitamins [57,76,77]. Recent years have been 
marked by a significant progress in our understanding 
of the essential role that bile acids play as signaling 
molecules regulating lipid, glucose and energy 
homeostasis and activating detoxification of xenobiotics 
[57,77,78]. By stimulating the G-protein-coupled 
receptor TGR5, bile acids activate the cAMP/PKA 
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in brown adipose tissue and muscle by stimulating 
mitochondrial oxidative phosphorylation and un-
coupling; 2) improves liver and pancreatic function by 
activating the endothelial nitric oxide synthase; and 3) 
enhances glucose tolerance in obese mice by inducing 
intestinal glucagon-like peptide-1 release [57,76,78]. 
Furthermore, by activating the farnesoid X receptor 
(FXR) and several other nuclear hormone receptors 
inside mammalian cells, bile acids 1) modulate the 
intracellular homeostasis of cholesterol, neutral lipids 
and fatty acids; 2) regulate glucose metabolism by 
enhancing glycogenesis and attenuating gluconeo-
genesis; and 3) stimulate clearance of xenobiotic and 
endobiotic toxins by activating transcription of 
numerous xenobiotic detoxification genes [57,76-78]. 
All these health-improving, beneficial metabolic effects 
of bile acids prevent the development of obesity 
following administration of high-fat diet [57,76,77]. 
Thus, bile acids have a great potential as pharmaceutical 
agents for the treatment of diabetes, obesity and various 
associated metabolic disorders, all of which are age-
related [57,76]. Moreover, bile acids have been shown 
to inhibit neuronal apoptosis in experimental rodent 
models of neurodegenerative disorders by promoting 
mitochondrial membrane stability, preventing the 
release of cytochrome c from mitochondria,  reducing 
activities of various caspases, and activating the NF-κB, 
PI3K and MAPK survival pathways [79,80]. 
 
It should be stressed that many of the metabolic, stress 
response and apoptotic processes modulated by bile 
acids in mammals are essential for healthy aging and 
longevity regulation. Importantly, we found that, by 
modulating several of these health- and longevity-
related processes in chronologically aging yeast, LCA 
increases their life span. Moreover, the long-lived 
Ghrhr
lit/lit mice displayed elevated levels of several bile 
acids and exhibited increased FXR-dependent 
transcription of numerous xenobiotic detoxification 
genes; if administered to food consumed by wild-type 
mice, cholic acid - one of these bile acids - mimicked 
the FXR-governed gene expression pattern observed in 
Ghrhr
lit/lit mice [81,82]. It has been therefore proposed 
that, by promoting chemical hormesis in mammals, 
these mildly toxic molecules with detergent-like 
properties may extend their longevity by acting as 
endobiotic regulators of aging [73,82,83]. 
 
Altogether, these findings support the notion that bile 
acids act as endobiotic and xenobiotic regulators of 
aging that are beneficial to health and longevity across 
phyla. A comparative analysis of the mechanisms 
underlying such health-improving and life-extending 
action of bile acids implies that these mechanisms are 




Yeast strains and growth conditions. The WT strain 
BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) and 
single-gene-deletion mutant strains in the BY4742 
genetic background (all from Open Biosystems) were 
grown in YP medium (1% yeast extract, 2% peptone) 
containing 0.2% 0.5%, 1% or 2% glucose as carbon 
source. Cells were cultured at 30
oC with rotational 
shaking at 200 rpm in Erlenmeyer flasks at a “flask 
volume/medium volume” ratio of 5:1. 
 
Chemical genetic screen for compounds that increase 
chronological life span (CLS). The screen was 
conducted at the High Throughput/Content Screening 
Facility at McGill University. The single-gene-deletion 
mutant strain pex5Δ ( MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0 pex5Δ::kanMX4) from Open Biosystems was 
grown in YPA0.5D medium (1% yeast extract, 2% 
peptone, 50 µg/ml ampicillin, 0.5% glucose). 3-µl 
aliquots of the pex5Δ  culture recovered from mid-
logarithmic phase at a cell titre of 2 ¯ 10
7 cells/ml were 
aliquoted into 96-well master microplates using a 
Beckman Coulter high density Biomek FXII replica 
pinning robot. Each well of a master microplate 
contained 96 µl of YPA0.5D medium. 1 µl of a 
compound stock solution from a commercially available 
library (each compound at 5 mM in dimethylsulfoxide 
(DMSO)) was added to each well using a Beckman 
Coulter high density Biomek FXII replica pinning 
robot. Wells of a master microplate supplemented with 
1% DMSO (1 µl of DMSO per a well containing 3 µl of 
the pex5Δ culture and 96 µl of YPA0.5D medium) were 
used as negative controls. Each master plate was created 
in duplicate. The master microplates were sealed and 
incubated without shaking at 30
oC in a moist chamber. 
At days 1, 7, 10 and 14 of the incubation of master 
microplates, a 3-µl aliquot of each culture was 
transferred into individual wells of a new (replica) 
microplate containing 97 µl of YPA0.5D medium. 
Following incubation of sealed replica microplates in a 
moist chamber for 16 hours at 30oC (to allow for 
growth of cells that were still viable), the optical 
density at 600 nm (OD600) of the culture in each well 
of the replica microplate was measured using a 
Molecular Devices  Analyst HT plate reader. To 
calculate survival at each time point, the OD600 at a 
particular time point was divided by the OD600 at day 
1. “Cherry-picking” of the identified “lead” com-
pounds for possible “hits” was carried out as described 
above, with each lead compound being used at a final 
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triplicate for validation. Commercially available 
structural analogs of hit compounds were identified 
using the web-based eMolecules searching engine. In 
total, approximately 19,000 representative compounds 
from the BIOMOL, Chembridge, Maybridge, 
MicroSource Discovery, NIH Clinical Collection, 
Prestwick Chemical Inc. and Sigma-LOPAC 
commercial libraries were tested using the screen for 
chemical modulators of longevity.   
 
Pharmacological manipulation of CLS. CLS analysis 
was performed as previously described [39]. The 
chenodeoxycholic (C9377), cholic (C1129), 
dehydrocholic (D3750), deoxycholic (D2510), 
hyodeoxycholic (H3878), lithocholic (L6250) and 
ursodeoxycholic (U5127) bile acids were from Sigma. 
Their stock solutions in DMSO were made on the day 
of adding each of these compounds to cell cultures. 
Compounds were added to growth medium at the 
indicated concentration immediately following cell 
inoculation. The final concentration of DMSO in yeast 
cultures supplemented with a bile acid (and in the 
corresponding control cultures supplemented with 
drug vehicle) was 1% (v/v). 
 
Miscellaneous procedures. Fluorescence [39], immuno-
fluorescence [39] and electron [84] microscopies 
followed by morphometric analyses of the resulting 
images have been described elsewhere. Extraction of 
lipids and their separation, identification and 
quantitation with the help of TLC were performed 
according to established procedures [84]. Mass 
spectrometric identification and quantitation of various 
lipid species were carried as previously described [85]. 
Subcellular fractionation and organelle purification, cell 
viability and stress resistance assays, oxygen 
consumption assay, the measurement of the frequencies 
of spontaneous point and deletion mutations in 
mitochondrial and nuclear DNA, total cell lysates 
preparation, and mass spectrometric identification and 
quantitation of proteins were performed according to 
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